Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Shortness of Breath and Fatigue in Hyperkyphosis

Understanding the Relationship Between Hyperkyphosis and Respiratory Symptoms

  • Hyperkyphosis may lead to decreased exercise capacity, which further contributes to deconditioning and worsening symptoms 1

Initial Assessment

  • Assess for potential underlying cardiac causes of dyspnea, as heart failure symptoms can mimic or coexist with respiratory limitations from hyperkyphosis 2, 3
  • Consider performing diastolic stress echocardiography in patients with unexplained dyspnea, as diastolic dysfunction may contribute to symptoms 1
  • Rule out exercise-induced bronchoconstriction through appropriate pulmonary function testing and exercise challenge when indicated 4, 5

Non-Pharmacological Management

Corrective Exercise Program

  • Appropriately tailored exercise helps improve functional capacity and addresses skeletal myopathy that may contribute to breathlessness 6

Respiratory Training

  • Incorporate breathing-relaxation training to improve respiratory efficiency 6, 7
  • Consider physiotherapeutic approaches including breathing training techniques, neuro-electrical leg muscle stimulation when appropriate, and use of walking aids to reduce energy expenditure 6

Pharmacological Management

Oxygen Therapy

  • Provide supplemental oxygen therapy for patients with documented hypoxemia 7
  • Oxygen therapy can ameliorate breathlessness in hypoxemic patients but is not supported for use in those who are only mildly hypoxemic or normoxemic 6

Symptomatic Treatment of Breathlessness

  • For persistent breathlessness despite optimization of underlying conditions, consider low-dose opioids 6, 7
  • Based on current evidence, oral low-dose sustained release morphine may be considered, starting at 10 mg per day 6
  • Monitor response to treatment, with potential dose adjustments after at least one week if needed (maximum 30 mg/24h) 6, 7
  • Use with caution in patients with renal impairment 7

Addressing Comorbidities

  • Optimize treatment of any underlying cardiac conditions that may contribute to symptoms 2, 3
  • Evaluate for and treat potential heart failure with preserved ejection fraction (HFpEF), which may present with similar symptoms 1, 2
  • Consider psychological interventions if anxiety or depression is contributing to symptom burden 6, 8

Monitoring and Follow-up

  • Adjust treatment plan based on response and progression of symptoms 5, 6

Special Considerations

  • In elderly patients, a multidisciplinary approach involving physical therapy, pulmonary rehabilitation, and cardiac care may be necessary 6, 8
  • Consider palliative care consultation for patients with advanced disease and significant symptom burden 6, 7

REFERENCES

4

exercise-induced bronchoconstriction update-2016. [LINK]

Journal of Allergy and Clinical Immunology, 2016

5

exercise-induced bronchoconstriction update-2016. [LINK]

Journal of Allergy and Clinical Immunology, 2016